mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathy
Steven Hyun Seung Lee(Korea Drug Research Association), Heuiran Lee(Asan Medical Center)
Cited by 13
Related Papers
Intravitreally Administered Soluble VEGF Receptor-1 Variant Tested as a Potential Gene Therapeutic for Diabetic Retinopathy
|Advances in Cell and Gene Therapy|2022|3